Cargando…
Strengthening clinical development activities and preparedness for vaccine manufacturers from emerging countries: Results of a survey
Vaccine development, in most cases, is a long, complex process, often lasting years and involving a combination of public and private stakeholders. Particularly, the vaccine clinical development process is highly regulated by several guidelines, regulatory pathways and science-based recommendations...
Autores principales: | Viviani, Simonetta, Willems, Paul, Pagliusi, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841010/ https://www.ncbi.nlm.nih.gov/pubmed/36654839 http://dx.doi.org/10.1016/j.jvacx.2022.100255 |
Ejemplares similares
-
Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers' perspectives
por: Jarrett, Stephen, et al.
Publicado: (2020) -
Emerging vaccine manufacturers are innovating for the next decade
por: Hayman, Benoit, et al.
Publicado: (2020) -
Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries
por: Pagliusi, Sonia, et al.
Publicado: (2023) -
Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers
por: Dellepiane, Nora, et al.
Publicado: (2020) -
Landscape analysis of pharmacovigilance and related practices among 34 vaccine manufacturers’ from emerging countries
por: Hartmann, Katharina, et al.
Publicado: (2020)